Showing results (1231-1240 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|July 9, 2021
Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survivalJebrane Bouaoud, Jean-Philippe Foy, Antonin Tortereau, et al.Oncoimmunology|July 5, 2021
Integrated analyses of m1A regulator-mediated modification patterns in tumor microenvironment-infiltrating immune cells in colon cancerYuzhen Gao, Hao Wang, Huiming Li, et al.Oncoimmunology|July 5, 2021
YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltrationZongcheng Yang, Guangxing Yan, Lixin Zheng, et al.Oncoimmunology|July 22, 2021
Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastomaJohn Choi, Ayush Pant, Ravi Medikonda, et al.Oncoimmunology|July 22, 2021
Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancersAdrien Joseph, Juncheng Pan, Judith Michels, et al.Oncoimmunology|December 14, 2020
Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patientsYun Gu, Yifan Chen, Kaifeng Jin, et al.Oncoimmunology|March 26, 2013
Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromesAdam W Mailloux, Pearlie K Epling-BurnetteOncoimmunology|March 26, 2013
Uncovering the mechanisms that regulate tumor-induced T-cell anergyBrian T Abe, Fernando MacianOncoimmunology|March 26, 2013
Strong emerging rationale for combining oncogene-targeted agents with immunotherapyYan Yang, Gregory Lizée, Patrick HwuOncoimmunology|March 26, 2013
Myeloid-derived suppressor sells and the efficacy of CD8+ T-cell immunotherapyAlexander M Lesokhin, Taha Merghoub, Jedd D WolchokPageof 380